Clinical interactions between human immunodeficiency virus and the human hepatitis viruses

Infectious Diseases in Clinical Practice

Volumn 8, Issue 1, 1999, Pages 9-20

  Lutwick, Larry I ^a,b  

^a SUNY DOWNSTATE MEDICAL CENTER   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHRONIC DISEASE; COMORBIDITY; DISEASE COURSE; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HOST SUSCEPTIBILITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOPATHOGENESIS; INFECTION RISK; PERSISTENT VIRUS INFECTION; SHORT SURVEY; VACCINATION;

EID: 0032927569     PISSN: 10569103     EISSN: None     Source Type: Journal    
DOI: 10.1097/00019048-199901000-00003     Document Type: Short Survey

References (118)

1. Romet-Lemonne J-LM, McClane MF, Elfassi E, et al. Hepatitis B infection in cultured lymphoblastoid cells. Science 1983;221:667-9.
2. Twu J-S, Schloemer RH. Transcriptional transactivating function of hepatitis B virus. J Virol 1987;61:3448-53.
3. Seto E, Yen TSB, Peterlin BM, et al. Trans-activation of the human immunodeficiency virus long terminal repeat by the hepatitis virus X protein. Proc Natl Acad Sci U S A 1988;85:8286-90.
4. Twu J-S, Robinson WS. Hepatitis B virus X gene can transactivate heterologous viral sequences. Proc Natl Acad Sci U S A 1988;86:2046-50.
5. Foster GR, Ackrill AM, Goldin RD, et al. Expression of the terminal protein region of hepatitis B virus inhibits cellular responses to interferons alpha and gamma and double-stranded RNA. Proc Natl Acad Sci U S A 1991;88:2888-92.
6. Sheron N, Lau J, Daniels H, et al. Increased production of tumour necrosis factor alpha in chronic hepatitis B infection. J Hepatol 1991;12:241-5.
7. Greenspan D, Greenspan JS, Overby G, et al. Risk factors for rapid progression from hairy leukoplakia to AIDS: a nested case-control study. J Acquir Immune Defic Syndr 1991;4:652-8.
8. Eskild A, Magnus P, Petersen G, et al. Hepatitis B antibodies in HIV-infected homosexual men are associated with more rapid progression to AIDS. AIDS 1992;6:571-4.
9. Solomon RE, VanRaden M, Kaslow RA, et al. Association of hepatitis B surface antigen and core antibody with acquisition and manifestations of human immunodeficiency virus type 1 (HIV-1) infection. Am J Public Health 1990;80:1475-8.
10. Gilson RJC, Hawkins AE, Beecham MR, et al. Interactions between HIV and hepatitis B virus in homosexual men: effects on the natural history of infection. AIDS 1997;11: 597-606.
11. Horvath J, Raffanti SP. Clinical aspects of the interactions between human immunodeficiency virus and the hepatotrophic viruses. Clin Infect Dis 1994;18:339-47.
12. Newell A, Francis N, Nelson M. Hepatitis and HIV: interrelationship and interactions. Br J Clin Pract 1995;49: 247-50.
13. McNair ANB, Main J, Thomas HC. Interactions of the human immunodeficiency virus and the hepatotropic viruses. Semin Liver Dis 1992;12:188-96.
14. Bodsworth NJ, Cooper DA, Donovan B. The influence of human immunodeficiency virus type-1 infection on the development of the hepatitis B carrier state. J Infect Dis 1991;163:1138-40.
15. Hadler SC, Judson FN, O'Malley PM, et al. Outcome of hepatitis B virus infection in homosexual men and its relation to prior human immunodeficiency virus infection. J Infect Dis 1991;163:454-9.
16. Bodsworth N, Donovan B, Nightingale BN. The effect of concurrent human immunodeficiency virus infection on chronic hepatitis B: a study of 150 homosexual males. J Infect Dis 1989;160:577-82.
17. Mai AL, Kim C, O'Rourke K, et al. The interaction of human immunodeficiency virus infection and hepatitis B virus infection in infected homosexual men. J Clin Gastroenterol 1996;22:299-304.
18. Mills CT, Lee E, Perrillo R. Relationship between histology, aminotransferase levels and viral replication in chronic hepatitis B. Gastroenterology 1990;99:519-24.
19. Bonacini M, Govindarajan S, Redeker AG. Human immunodeficiency virus infection does not alter serum transaminases and hepatitis B virus (HBV) DNA in homosexual patients with chronic HBV infection. Am J Gastroenterol 1991;86:570-5.
20. Perrillo RP, Regenstein FG, Roodman ST. Chronic hepatitis B in asymptomatic homosexual men with antibody to the human immunodeficiency virus. Ann Intern Med 1986;105:382-3.
21. Vento S, di Perri G, Luzzati R, et al. Clinical reactivation of hepatitis B in anti-HBs-positive patients with AIDS. Lancet 1989;1:332-3.
22. Vento S, di Perri G, Garofano T, et al. Reactivation of hepatitis B in AIDS. Lancet 1989;2:108-9.
23. Lazizi Y, Grangeot-Keros L, Delfraissy JF, et al. Reappearance of hepatitis B virus in immune patients infected with the human immunodeficiency virus. J Infect Dis 1988;158:666-7.
24. Homann C, Krogsgaard K, Pedersen C, et al. High incidence of hepatitis B infection and evolution of chronic hepatitis B infection in patients with advanced HIV infection. J Acquir Immune Defic Syndr 1991;4: 416-20.
25. Levy P, Marcellin P, Martinot-Peignoux M, et al. Clinical course of spontaneous reactivation of hepatitis B virus infection in patients with chronic hepatitis B. Hepatology 1990;12:570-4.
26. di Martino V, Lunel F, Cadranel JF, et al. Long-term effects of interferon-alpha in five HIV-position patients with chronic hepatitis B. J Viral Hepat 1996;3:253-60.
27. Perrillo RP, Regenstein FG, Peters MG, et al. Prednisolone withdrawal followed by recombinant alpha interferon in the treatment of chronic type B hepatitis. Ann Intern Med 1988;109:95-100.
28. Haritami H, Uchida T, Okuda Y, et al. Effect of 3′-azido-3′deoxythymidine on replication of duck hepatitis B virus in vivo and in vitro. J Med Virol 1989;29:244-8.
29. Gilson RJ, Hawkins AE, Kelly GK, et al. No effect of zidovudine on hepatitis B virus replication in homosexual men with symptomatic HIV-1 infection. AIDS 1991;5: 217-20.
30. Hess G, Rossol S, Voth R, et al. Treatment of patients with chronic type B hepatitis and concurrent human immunodeficiency virus with a combination of interferon alpha and azidothymidine. Digestion 1989;43:56-9.
31. Benhamou Y, Katlama C, Lunel F, et al. Effects of lamivudine on replication of hepatitis B virus in HIV-infected men. Ann Intern Med 1996;125:705-12.
32. Dienstag J, Schiff E, Wright T, et al. Lamivudine treatment for one year in previously untreated U.S. hepatitis B patients: histologic improvement and hepatitis B e antigen seroconversion. Gastroenterology 1998;114:A1235.
33. Melegari M, Scaglioni PP, Wands JR. Hepatitis B virus mutants associated with 3TC and famciclovir administration are replication defective. Hepatology 1998;27: 628-33.
34. Carr A, Cooper DA. Restoration of immunity to chronic hepatitis B infection in HIV-infected patient on protease inhibitor. Lancet 1997;347:995-6.
35. Collier AC, Corey L, Murphy VL, et al. Antibody to human immunodeficiency virus (HIV) and suboptimal response to hepatitis B vaccination. Ann Intern Med 1988;109:101-5.
36. Carne CA, Weller IVD, Waite J, et al. Impaired responsiveness of homosexual men with HIV antibodies to plasma derived hepatitis B vaccine. Br J Med 1987;294: 866-8.
37. Wong EK, Bodsworth NJ, Slade MA, et al. Response to hepatitis B vaccination in a primary care setting: influence of HIV infection, CD4+ lymphocyte count and vaccination schedule. Int J STD AIDS 1996;7:490-4.
38. Cheeseman SH, Davaro RE, Ellison RT. Hepatitis B vaccination and plasma HIV-1 RNA [letter]. N Engl J Med 1996;334:1272.
39. Hadler SC, Francis DP, Maynard JE, et al. Long-term immunogenicity and efficacy of hepatitis B vaccine in homosexual men. N Engl J Med 1986;315:209-14.
40. Biggar RJ, Goedert JJ, Hoof nagle J. Accelerated loss of antibody to hepatitis B surface antigen among immunodeficient homosexual men infected with HIV. N Engl J Med 1987;316:630-1.
41. Quan MC, Krajden M, Grijorian GA, et al. Hepatitis C virus infection in patients infected with the human immunodeficiency virus. Clin Infect Dis 1993;17:117-9.
42. Libre JM, Garcia E, Aloy A, et al. Hepatitis C virus and progression of infection due to human immunodeficiency virus [letter]. Clin Infect Dis 1993;16:182.
43. Dorrucci M, Pezzotti P, Phillips AN, et al. Coinfection of hepatitis C virus with human immunodeficiency virus and progression to AIDS. J Infect Dis 1995;172: 1503-8.
44. Wright TL, Hollander H, Pu X, et al. Hepatitis C in HIV-infected patients with and without AIDS: prevalence and relationship to patient survival. Hepatology 1994;20: 1152-5.
45. Sabin CA, Telfer P, Phillips AN, et al. The association between hepatitis C virus genotype and human immunodeficiency virus disease progression in a cohor: of hemophilic men. J Infect Dis 1997;175:164-8.
46. Srinivas RV, Ray RB, Meyer K, et al. Hepatitis C virus core protein inhibits human immunodeficiency virus type 1 replication. Virus Res 1996;45:87-92.
47. Stokes MB, Chawla H, Brody RI, et al. Immune complex glomerulonephritis in patients coinfected with human immunodeficiency virus and hepatitis C virus. Am J Kidney Dis 1997;29:514-25.
48. Zylerberg H, Pol S. Reciprocal interactions between human immunodeficiency virus and hepatitis C virus. Clin Infect Dis 1996;23:1117-23.
49. Pol S, Rothschild C, Poussin K, et al. HIV coinfection does not modify HCV infection profile in hemophiliacs [abstract]. J Hepatol Suppl 1994;21:S122.
50. Collier J, Heathcote J. Hepatitis C viral infection in the immunosuppressed patient. Hepatology 1998;27:2-6.
51. Hayashi PH, Flynn N, McCurdy SA, et al. Prevalence of hepatitis C virus antibodies among patients infected with human immunodeficiency virus. J Med Virol 1991;33: 177-80.
52. Chamot E, Hirschel B, Wintsch J, et al. Loss of antibodies against hepatitis C virus in HIV-seropositive intravenous drug users. AIDS 1990;4:1275-7.
53. Ragni MV, Ndimbie OK, Rice EO, et al. The presence of hepatitis C virus (HCV) antibody in human immunodeficiency virus positive hemophilic men undergoing HCV "seroreversion." Blood 1995;82:1010-5.
54. Marcellin P, Martinot-Peignoux M, Elias A, et al. Hepatitis C virus (HCV) viremia in human immunodeficiency virus-seronegative and -seropositive patients with indeterminant HCV recombinant immunoblot assay. J Infect Dis 1994;170:433-5.
55. Cribier B, Rev D, Uhl G, et al. Quantification of hepatitis C virus RNA in peripheral blood mononuclear cells: a comparison between patients chronically infected by HCV and patients coinfected by HIV. Res Virol 1996; 147:325-32.
56. Cribier B, Rey D, Schmitt C, et al. High hepatitis C viremia and impaired antibody response in patients coinfected with HIV. AIDS 1995;9:1131-6.
57. Thomas DL, Shih JW, Alter HJ, et al. Effect of human immunodeficiency virus on hepatitis C infection among injecting drug users. J Infect Dis 1996;174:690-5.
58. Berger A, von Depka Prondzinski M, Doerr HW, et al. Hepatitis C plasma viral load is associated with HCV genotype but not HIV coinfection. J Med Virol 1996; 48:339-43.
59. Cribier B, Schmitt C, Rey C, et al. HIV increases hepatitis C viraemia irrespective of the hepatitis C virus genotype. Res Virol 1997;148:267-71.
60. Ghany MG, Leissinger C, Lagier R, et al. Effect ot human immunodeficiency virus on hepatitis C virus infection in hemophiliacs. Dig Dis Sci 1996;41:1265-72.
61. Eyster ME, Fried MW, Bisceglie AM, et al. Increasing hepatitis C virus RNA levels in hemophiliacs: relationship to human immunodeficiency virus infection and liver disease. Blood 1994;84:1020-3.
62. Telfer PT, Brown D, Devereux H, et al. HCV RNA levels and HIV infection: evidence for a viral interaction in hemophilic patient. Br J Haematol 1994;88:397-9.
63. Picchio GR, Nakatsuno M, Boggiano C, et al. Hepatitis C (HCV) genotype and viral titer distribution among Argentinean hemophiliac patients in the presence or absence of human immunodeficiency virus (HIV) co-infection. J Med Virol 1997;52:219-25.
64. Kim JL, Morgenstern KA, Lin C, et al. Crystal structure of the hepatitis C virus NS3 protease domain complexes with a synthetic NS4A cofactor peptide. Cell 1996;87: 343-55.
65. Rutschmann OT, Negro F, Hirschel B, et al. Impact of treatment with human immunodeficiency virus (HIV) protease inhibitors on hepatitis C viremia in patients coinfected with HIV. J Infect Dis 1998;177:783-5.
66. Bjorkander J, Cunningham-Rundles C, Lundin P, et al. Intravenous immunoglobulin prophylaxis causing liver damage in 16 of 77 patients with hypogammaglobulinemia or IgG subclass deficiency. Am J Med 1988;84: 107-11.
67. Bjoro K, Froland SS, Yun Z, et al. Hepatitis C infection in patients with primary hypogammaglobulinemia after treatment with contaminated immune globulin. N Engl J Med 1994;331:1607-11.
68. Roudot-Thoraval F, Bastie A, Pawlotsky J-M, et al. Epidemiological factors affecting the severity of hepatitis C virus-related liver: a French survey of 6,664 patients. Hepatology 1997;26:485-90.
69. Soto B, Sanchez-Quijano A, Roclrigo L, et al. Human immunodeficiency virus infection modifies the natural history of chronic parenterally-acquired hepatitis C with an unusually rapid progression to cirrhosis. J Hepatol 1997; 26:1-5.
70. Ridzan R, Gallagher K, Ciesielski C, et al. Simultaneous transmission of human immunodeficiency virus and hepatitis C from a needle stick injury. N Engl J Med 1997;336:919-22.
71. Dragoni F, Mazzucconi MG, Cafolla A, et al. Rapid liver failure related to chronic C hepatitis in an HIV seropositive hemophilic patient with severe immunodepression. Haematologica 1996;81:335-8.
72. Martin P, DiBisceglie AM, Kassianides C, et al. Rapidly progressive non-A, non-B hepatitis in patients with human immunodeficiency virus infection. Gastroenterology 1989;97:1559-61.
73. Libranore M, Bicocchi R, Signinolfi R, et al. Fulminant NANB hepatitis in a patient with AIDS: a possible demonstration of direct hepatic damage by the virus(es) involved [letter]? Infection 1988;16:255.
74. Rockstroh JK, Spengler U, Sudhop T, et al. Immunosuppression may lead to progression of hepatitis C virus-associated liver disease in hemophiliacs coinfected with HIV. Am J Gastroenterol 1996;91:2563-8.
75. Areias J, Lopes I. Influence of HIV infection on chronic hepatitis C in intravenous drug addicts. Hepatology 1992;16(Suppl 2):195A.
76. Bierhoff E, Fischer HP, Willsch E, et al. Liver histopathology in patients with concurrent chronic hepatitis C and HIV infection. Virchows Arch 1997;430:271-7.
77. Pol S, Trinh T, Thiers V, et al. Chronic hepatitis of drug users: influence of HIV infection. Hepatology 1995;22: 340A.
78. Bartholomew C, Piliero PJ, Szebenyi S, et al. Recombinant interferon therapy for chronic hepatitis C in patients with HIV infection. Gastroenterology 1998;114:A1209.
79. Boldorini R, Vigano P, Monga G, et al. Hepatic histology of patients with HIV infection and chronic hepatitis C treated with interferon. J Clin Pathol 1997;50:735-40.
80. Marcellin P, Boyer N, Arejas J, et al. Comparison of efficacy of alpha interferon in former intravenous drug addicts with chronic hepatitis C with or without HIV infection. Gastroenterology 1994;106:A938.
81. Soriano V, Bravo R, Garcia-Samaniego J, et al. CD4+ T-lymphocytopenia in HIV infected patients receiving interferon therapy for chronic hepatitis C. AIDS 1994;8:1621-34.
82. Sherman KE, Andreatta C, O'Brien J, et al. Hepatitis C in human immunodeficiency virus-coinfected patients: increased variability in the hypervariable envelope coding domain. Hepatology 1996;23:688-94.
83. Soriano V, Garcia-Samaneigo J, Bravo R, et al. Efficacy and safety of alpha-interferon treatment for chronic hepatitis C in HIV-1 infected patients. J Infect 1995;31:9-13.
84. Vento S, Di Perri G, Cruciani M, et al. Rapid decline of CD4+ cells after IFN alpha treatment in HIV-1 infection. Lancet 1993;341:858-9.
85. Kwo PY, Pound DC, Fields S, et al. Combination therapy with ribavirin plus alpha interferon for the treatment of chronic hepatitis secondary to hepatitis C virus in patients who have failed treatment with alpha interferon. Gastroenterology 1998;114:A1279.
86. Olmeda M, Khalili M, Perrillo RP. Amantidine monotherapy in patients with chronic hepatitis C. Gastroenterology 1998;114:A1316.
87. Casey JL. Hepatitis delta virus: genetics and pathogenesis. Clin Lab Med 1996;16:451-64.
88. Shattock AG, Irwin FM, Morgan BM, et al. Increased severity and morbidity of acute hepatitis in drug abusers with simultaneously acquired hepatitis B and hepatitis D virus infections. Br Med J (Clin Res Ed) 1985;290:1377-80.
89. Rizzetto M, Shin J-W, Gocke DJ, et al. Incidence and significance of antibodies to delta antigen in hepatitis B infection. Lancet 1979;2:986-90.
90. Eyster ME, Sanders JC, Battegay M, DiBisceglie AM. Suppression of hepatitis C virus (HCV) replication by hepatitis D virus (HDV) in HIV-infected hemophiliacs with chronic hepatitis B and C. Dig Dis Sci 1995;40:1583-8.
91. Buti M, Jardi R, Allende H, et al. Chronic delta hepatitis: is the prognosis worse when associated with hepatitis C virus and human immunodeficiency virus infections? J Med Virol 1996;49:66-9.
92. Pol S, Wesenfelder L, Dubois F, et al. Influence of human immunodeficiency virus infection on hepatitis delta virus superinfection in chronic HBsAg carriers. J Viral Hepat 1994;1:131-7.
93. Castillo I, Bartolomé J, Madejón A, et al. Hepatitis delta virus RNA detection in chronic HBsAg carriers with and without HIV infection. Digestion 1991;48:149-56.
94. Novick DM, Farci P, Croxson TS, et al. Hepatitis D virus and human immunodeficiency virus antibodies in parenteral drug abusers who are hepatitis B surface antigen positive. J Infect Dis 1988;158:795-803.
95. Kreek MJ, Des Jarlais DC, Trepo DM, et al. Contrasting prevalence of delta hepatitis markers in parenteral drug abusers with and without AIDS. J Infect Dis 1990;162: 538-41.
96. Lake-Bakaar G, Bhat K, Govindarajan S. The effect of HIV disease on serum markers of hepatitis delta infection in intravenous drug abusers. J Lab Clin Med 1994;124:564-8.
97. Grippon P, Ribiere O, Cadranel JF, et al. Long-term delta antigenaemia without appearance of delta antibody in two immunodeficient patients [letter]. Lancet 1987;1:1031.
98. Batts KP. Hepatitis G: a virus in search of a disease. Am J Clin Pathol 1997;108:616-8.
99. Theodore D, Lemon SM. GB virus C, hepatitis G virus, or human orphan flavivirus? Hepatology 1997;25:1285-6.
100. Stark K, Bienzle U, Hess G, et al. Detection of the hepatitis G virus genome among injecting drug users, homosexual and bisexual men, and blood donors. J Infect Dis 1996;174:1320-3.
101. Nishiwara T, Okamoto H, Konishi K, et al. A novel DNA virus (TTV) associated with elevated transaminase levels in posttransfusion hepatitis of unknown etiology. Biochem Biophys Res Comm 1997;241:92-7.
102. Mannucci PM, Godvin S, Gringeri A, et al. Transmission of hepatitis A to patients with hemophilia by factor VII concentrates treated with organic solvents and detergent to inactivate viruses. The Italian Collaborative Group. Ann Intern Med 1994;120:1-7.
103. Wilner IR, Uhl MD, Howard SC, et al. Serious hepatitis A: an analysis of patients hospitalized during an urban epidemic in the United States. Ann Intern Med 1998;128:111-4.
104. Fujiwara K, Yokosuka O, Ehata T, et al. Frequent detection of hepatitis A viral RNA in serum during the early convalescent phase of acute hepatitis A. Hepatology 1997;26:1634-9.
105. Inoue K, Yoshiba M, Yotsuyanagi H, et al. Chronic hepatitis A with persistent viral replication. J Med Virol 1996;50:322-4.
106. Wilfert CM, Buckley RH, Mohanakumar T, et al. Persistent and fatal central nervous system ECHOvirus infections in patients with agammaglobulinemia. N Engl J Med 1977;296:1485-9.
107. Vento S, Garofano T, Renzini C, et al. Fulminant hepatitis associated with hepatitis A virus superinfection in patients with chronic hepatitis C. N Engl J Med 1998; 338:286-90.
108. Tilzey AJ, Palmer SJ, Harrington C, et al. Hepatitis A vaccine responses in HIV-positive persons with haemophilia. Vaccine 1996;14:1039-41.
109. Hess G, Clemens R, Bienzle U, et al. Immunogenicity and safety of an inactivated hepatitis A vaccine in antiHIV positive and negative homosexual men. J Med Virol 1995;46:40-2.
110. Krawczynski K. Hepatitis E. Hepatology 1993;17: 932-41.
111. Kwo PY, Schlauder GG, Carpenter HA, et al. Acute hepatitis E by a new isolate acquired in United States. Mayo Clin Proc 1997;72:1133-6.
112. Meng X-J, Purcell RH, Halbur PG, et al. A novel virus in swine is closely related to the human hepatitis E virus. Proc Natl Acad Sci U S A 1997;94:9860-5.
113. Montella E, Rezza G, Di Sora F, et al. Association between hepatitis E virus and HIV infection in homosexual men [letter]. Lancet 1994;344:1433.
114. Gessoni G, Manoni F. Hepatitis E virus infection in north-east Italy: serological study in open population and groups at risk. J Viral Hepat 1996;3:197-202.
115. Medrano FJ, Sanchez-Quijano A, Torronteras R, et al. Hepatitis E virus and HIV infection in homosexual men [letter]. Lancet 1995;345:127.
116. Bissuel F, Houhou N, Leport C, et al. Hepatitis E antibodies and HIV status. Lancet 1996;347:1494.
117. Barzilai A, Schulman S, Kuretnyi YV, et al. Hepatitis E virus infection in hemophiliacs. J Med Viral 1995; 46:153-6.
118. Ozaki Y, Tajiri H, Mushiake S, et al. Persistent liver dysfunction in children associated with human herpesvirus-6 (HHV-6) infection: clinical features and in situ hybridization study. Gastroenterology 1998;114: A1318.